3. Lab Analysis: The sample is sent to a lab, where it is analyzed for genetic markers related to depression and medication ...

Michael Gendreau, MD, Chief Medical Officer of Dogwood Therapeutics, stated: “The primary goals of this trial were to determine the IMC-2 treatment effect size versus placebo and the associated ...

Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership with ALZpath, Inc to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's ...

Dogwood Therapeutics, Inc. (DWTX), a development-stage biotechnology company, announced on Monday the top-line data from the recently ...

After reviewing a sample of reported child abuse or neglect cases from 2021 and 2022 ... The audit is part of a series from ...

The research found that two-fifths (41%) of American parents would rather spend money on a trip of a lifetime in 2025 than ...

The study examined AI’s potential to enable would-be bioterrorists that would otherwise lack the skill and confidence to plan ...

The failure of the Eyenovia CHAPERONE study has seen the company’s stock value drop drastically as it weighs up options and ...

Browns head coach Kevin Stefanski took questions from reporters on Monday regarding the 35-14 loss to the Saints, Dawand ...

Kevin Stefanski specified on Monday that left tackle Dawand Jones broke his left fibula during Sunday’s 35-14 loss to the ...

Nearly 7 million Americans live with Alzheimer’s disease, a number expected to double by 2060. While aging and genetics are ...

Portuguese brewing major Super Bock is to invest €10m ($10.5m) in its Vitalis mineral water business, it has announced.